Aehr Test Systems, Inc. (AEHR) supplies equipment used to test, "burn in," and stabilize semiconductor devices before shipment. Burn-in stresses chips at elevated temperatures and voltages to catch early failures. By enabling this at the wafer level, before packaging, Aehr helps manufacturers identify defects earlier and more cost-effectively. The company draws attention because its technology sits at the intersection of artificial intelligence processors and power semiconductors.
Founded in 1977 by Rhea J. Posedel and headquartered in Fremont, California, Aehr went public on the Nasdaq in 1997 with a fiscal year ending in May. Gayn Erickson serves as chief executive officer. The firm operates as a single segment focused on designing, manufacturing, marketing, and selling advanced test and burn-in products for the semiconductor industry.
Core offerings include the FOX-XP, FOX-NP, and FOX-CP wafer-contact test and burn-in systems, the FOX WaferPak contactor for full-wafer testing, the FOX DiePak carrier for singulated bare die, and the Sonoma family of ultra-high-power package-level burn-in systems acquired in 2024 from Incal Technology. Revenue comes from capital equipment sales and recurring consumables like WaferPak contactors and DiePak carriers. Sales occur directly and through distributors in the United States, Asia, and Europe. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
In the semiconductor equipment space, Aehr specializes in wafer-level test and burn-in, a niche within the automated test equipment market led by larger players such as Teradyne (TER) and Advantest. It competes through proprietary full-wafer contactor technology and high-power parallel testing rather than scale.
Historically, silicon carbide power semiconductors for electric vehicles and charging infrastructure represented the largest market, alongside gallium nitride devices, silicon photonics for data-center connectivity, flash memory, and automotive sensors. More recently, AI processors have emerged as the fastest-growing segment as chipmakers adopt wafer-level burn-in to screen high-value accelerators before expensive packaging.
Investors track Aehr mainly for its exposure to reliability testing tied to artificial intelligence and data-center infrastructure. Larger, more complex AI accelerators create stronger incentives to detect defects before multi-die packaging, supporting demand for wafer-level solutions. The company has also broadened its customer and end-market base, easing earlier reliance on electric-vehicle silicon carbide.
Its edge comes from proprietary WaferPak technology and the ability to test multiple high-power wafers in parallel, which can boost throughput for customers. The consumables business adds an element of recurring revenue from an installed base built over decades. These elements position Aehr in a specialized corner of a growing semiconductor equipment market. From what I see, this combination of technology and market shifts is worth monitoring closely.
Several factors warrant attention. Aehr maintains a concentrated customer base where a small number of large buyers have historically driven a substantial portion of revenue, leaving results vulnerable to individual purchasing decisions. The semiconductor equipment industry is cyclical, so revenue can swing with capacity planning and large order timing.
Competition from much larger, better-capitalized rivals remains intense. Growth hinges on broader adoption of wafer-level burn-in in AI, silicon photonics, and power applications. Technological shifts, patent issues, and macroeconomic or trade factors affecting capital spending can all affect performance. At its current revenue scale, results and share price tend to show notable volatility.
When analyzing names like Aehr, I often turn to Tickeron’s AI Screener to quickly compare technical indicators, fundamentals, and industry trends across thousands of stocks. It helps surface ideas that align with specific strategies without replacing my own due diligence.
Aehr Test Systems holds a focused role in semiconductor equipment through wafer-level and package-level test and burn-in solutions. Its proprietary full-wafer contactor technology, long-established installed base, and growing presence in AI and data-center applications set it apart from larger, more general test-equipment providers. For investors, it offers a targeted way to access semiconductor reliability testing, though customer concentration and cyclical demand call for careful evaluation.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for AEHR moved out of oversold territory on November 03, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 29 of the 31 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on AEHR as a result. In 71 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on November 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 35 of 38 cases over the following month. The odds of a continued upward trend are 90%.
Following a +21.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 243 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
AEHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 54 of 63 cases where AEHR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 86%.
The 10-day moving average for AEHR crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for AEHR entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.970) is normal, around the industry mean (5.670). AEHR has a moderately low P/E Ratio (-232.913) as compared to the industry average of (68.795). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 74 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment